GENZYME CORP: ‘775 Patent Dispute with Impax Remains Ongoing

Genzyme Corporation remains in dispute with Impax Laboratories, Inc. over U.S. Patent No. 5,667,775, which expires in 2014.

The Company received notice in 2009, from Impax that it had submitted to…

CANDELA CORP: Cardiofocus Patent Suit Stayed Pending PTO Re-exam

Cardiofocus, Inc.’s patent infringement suit against Candela Corporation remains stayed pending the U.S. Patent & Trademark Office’s re-examination proceedings.

On Feb. 19, 2008, Cardiofocus filed suit against the Company and eight…

CANDELA CORP: Palomar’s Bid to Lift Stay in Patent Suit Pending

The U.S. District Court for the District of Massachusetts has yet to rule on Palomar Medical Technologies, Inc.’s motion to lift the stay in its patent infringement action against Candela…

CANDELA CORP: USPTO’s ‘222 Patent Re-examination Remains Ongoing

The U.S. Patent and Trademark Office’s re-examination of Candela Corporation’s U.S. Patent No. 6,743,222 remains ongoing.

On Aug. 10, 2006, the Company filed suit against Palomar Medical Technologies, Inc., in the…

AMGEN INC: Ruling on La-Roche’s Appeal to Patent Ruling Pending

F. Hoffmann-La Roche Ltd.’s appeal from the U.S. District Court for the District of Massachusetts’ final judgment in Amgen Inc.’s lawsuit alleging infringement of its erythropoietin patents remains pending with…

GENZYME CORP: Pursues Hectorol Patent Action v. Roxane in Del.

Genzyme Corporation is pursuing a Hectorol patent infringement action against Roxane Laboratories, Inc., in the U.S. District Court for the District of Delaware.

On July 31, 2009, the company filed a…

GENZYME CORP: Pursues Patent Infringement Suits v. Lupin, Impax

Genzyme Corporation is pursuing lawsuits against Lupin Ltd. and Lupin Pharmaceuticals and Impax Laboratories, Inc., alleging infringement of Renagel and Renvela patents.

Beginning in January 2009, the company received notices from…

GENZYME CORP: Pursues Amended Hectorol Patent Suit v. Pentech

Genzyme Corporation is pursuing an amended patent infringement complaint against Pentech Pharmaceuticals, Inc.

In January 2008, the company received notice that Pentech had submitted to the U.S. Food and Drug Administration…

GENZYME CORP: Hectorol Patent Suit v. Eagle Pending in Delaware

Genzyme Corporation’s patent infringement suit against Eagle Pharmaceuticals, Inc., remains pending in the U.S. District Court for the District of Delaware.

In March 2009, the company received notice that Eagle had…

GENZYME CORP: In Dispute with Sandoz Over Renagel Patent Breach

Genzyme Corporation is engaged in dispute with Sandoz, Inc., over infringement of the Renagel patent.

The company on July 2, 2009, filed a complaint against Sandoz in the U.S. District Court…

Page 1 of 512345»